Arctic Bioscience AS (9TD) Financial Statements
Arctic Bioscience AS Financial Overview
Arctic Bioscience AS's market cap is currently $5.77M. The company's EPS TTM is $-1.49; its P/E ratio is -1.48; Arctic Bioscience AS has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 40.10M | $ 43.48M | $ 33.76M | $ 34.27M | $ 21.52M |
| Gross Profit | $ -33.71M | $ 11.89M | $ 9.78M | $ 11.65M | $ 5.16M |
| Operating Income | $ -35.97M | $ -47.79M | $ -48.59M | $ -37.39M | $ 40.58M |
| EBITDA | $ -30.85M | $ -39.63M | $ -43.20M | $ -30.29M | $ -37.94M |
| Net Income | $ -41.03M | $ -47.93M | $ -45.51M | $ -34.02M | $ -42.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.29M | $ 2.16M | $ 79.60M | $ 144.15M | $ 227.36M |
| Total Assets | $ 284.65M | $ 279.74M | $ 300.25M | $ 327.70M | $ 341.47M |
| Total Debt | $ 62.32M | $ 32.86M | $ 2.05M | $ 1.10M | $ 4.18K |
| Net Debt | $ 61.03M | $ 30.70M | $ -77.55M | $ -143.05M | $ -227.36M |
| Total Liabilities | $ 111.17M | $ 69.01M | $ 41.69M | $ 40.42M | $ 20.92M |
| Stockholders' Equity | $ 173.49M | $ 210.73M | $ 258.56M | $ 287.28M | $ 320.55M |
| Cash Flow | |||||
| Free Cash Flow | $ -45.40M | $ -96.17M | $ -85.62M | $ -83.96M | $ -76.00M |
| Operating Cash Flow | $ -22.65M | $ -45.36M | $ -40.29M | $ -25.40M | $ -39.49M |
| Investing Cash Flow | $ -22.70M | $ -50.63M | $ -43.10M | $ -58.57M | $ -36.50M |
| Financing Cash Flow | $ 43.36M | $ 19.66M | $ 18.84M | $ 749.99K | $ 290.76M |
Currency in NOK
